Metropolitan Life Insurance CO Immunic, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$3.13 - $12.25 $4,356 - $17,052
-1,392 Closed
0 $0
Q1 2022

Jun 20, 2023
BUY
$9.54 - $14.26 $13,279 - $19,849
1,392 New
1,392 $15,000
Q1 2022

Mar 30, 2023
BUY
$9.54 - $14.26 $13,279 - $19,849
1,392 New
1,392 $15,000
Q1 2022

May 12, 2022
BUY
$9.54 - $14.26 $13,279 - $19,849
1,392 New
1,392 $16,000

Others Institutions Holding IMUX

# of Institutions
70
Shares Held
56.3M
Call Options Held
100
Put Options Held
350K
View Full List

About IMMUNIC, INC.

IMUX Quotes by TradingView
  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $29.3M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email